Lena Specht, MD, DMSc, discusses data for mogamulizumab in Danish patients with mycosis fungoides or Sezary syndrome and their effect on clinical practice.
Lena Specht, MD, DMSc
Advertisement
Lena Specht, MD, DMSc, is a professor of oncology at the Faculty of Health Sciences and Chief Oncologist at Rigshopitalet at the University of Copenhagen.
Articles by Lena Specht, MD, DMSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
CHMP Recommends Pirtobrutinib for EU Approval in CLL Across All Lines of Therapy
2
Generic Enzalutamide Tablets Granted Tentative FDA Approval for Prostate Cancer
3
FDA Approves Prefilled Pen for Ropeginterferon Alfa-2b in Polycythemia Vera
4
ST-001 nanoFenretinide Shows Antitumor Activity in Previously Treated Cutaneous T-Cell Lymphoma
5